Bicycle Therapeutics (BCYC) Retained Earnings (2018 - 2026)
Bicycle Therapeutics (BCYC) posted Retained Earnings of -$960.6 million for Q1 2026, down 6.76% on a QoQ basis from -$899.8 million in Q4 2025, and down 29.54% year-over-year from -$1.4 billion in Q1 2025.
Bicycle Therapeutics (BCYC) Retained Earnings (2018 - 2026) Analysis & Trends
Bicycle Therapeutics' Retained Earnings history runs 9 years deep, the most recent figure standing at -$960.6 million for Q1 2026.
- Quarterly Retained Earnings fell 29.54% year-over-year to -$960.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$960.6 million (down 29.54% YoY) and the FY2025 annual result came in at -$899.8 million, down 32.16% from the prior year.
- Retained Earnings was -$960.6 million for Q1 2026 at Bicycle Therapeutics, down from -$899.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.5 billion in Q3 2024 and bottomed at -$960.6 million in Q1 2026.
- A 5-year average of -$51.6 million and a median of -$245.9 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings jumped 17842.18% — and 2025, when it slumped 95208.48%.
- Bicycle Therapeutics' Retained Earnings stood at $601.1 million in 2022, then sank by 100.22% to -$1.3 million in 2023, then sank by 52107.9% to -$680.8 million in 2024, then tumbled by 32.16% to -$899.8 million in 2025, then declined by 6.76% to -$960.6 million in 2026.
- Business Quant data shows BCYC's Retained Earnings at -$960.6 million in Q1 2026, -$899.8 million in Q4 2025, and -$879.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | -960.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -960.58 Mn |
| Dec 31, 2025 | -899.75 Mn |
| Sep 30, 2025 | -879.60 Mn |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | -741.50 Mn |
| Dec 31, 2024 | -680.79 Mn |
| Sep 30, 2024 | 1.46 Bn |
| Jun 30, 2024 | 1.45 Bn |
| Mar 31, 2024 | -778,000.00 |
| Dec 31, 2023 | -1.30 Mn |
| Sep 30, 2023 | -462.70 Mn |
| Jun 30, 2023 | -412.76 Mn |
| Mar 31, 2023 | 612.86 Mn |
| Dec 31, 2022 | 601.11 Mn |
| Sep 30, 2022 | -301.10 Mn |
| Jun 30, 2022 | 584.15 Mn |
| Mar 31, 2022 | -245.94 Mn |
| Dec 31, 2021 | -3.39 Mn |
| Sep 30, 2021 | 374.03 Mn |
| Jun 30, 2021 | -185.70 Mn |